Chronic cough, defined as a cough persisting beyond eight weeks, poses a significant diagnostic and therapeutic challenge in clinical practice. It can be a symptom of an underlying condition or a disease entity in itself. This article aims to provide a comprehensive approach to its management.
Identifying the cause is the first step in managing chronic cough. Common etiologies include gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS) secondary to rhinosinus conditions. Less common causes, such as lung cancer, should also be considered in high-risk patients. A detailed history, physical examination, and appropriate diagnostic tests are crucial in this phase.
Treatment should be directed at the underlying cause. For example, proton pump inhibitors may be beneficial in GERD-associated cough, while inhaled corticosteroids are the treatment of choice for asthma-related cough. In cases where chronic cough is a disease in itself, centrally acting agents like gabapentin and amitriptyline have shown efficacy.
Despite a comprehensive approach, a subset of patients remains with idiopathic chronic cough. In these cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be beneficial. Future research should focus on understanding the pathophysiology of chronic cough better and developing targeted therapies.
Managing chronic cough requires a systematic approach to identify the underlying cause and provide targeted treatment. Despite current strategies, chronic cough remains a therapeutic challenge, underscoring the need for continued research and multidisciplinary collaboration.
1.
A new way to measure suicide risk?
2.
3D virtual staining technology enables non-invasive observation of cancer tissue
3.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation